<code id='602DB91B80'></code><style id='602DB91B80'></style>
      • <acronym id='602DB91B80'></acronym>
      <center id='602DB91B80'><center id='602DB91B80'><tfoot id='602DB91B80'></tfoot></center><abbr id='602DB91B80'><dir id='602DB91B80'><tfoot id='602DB91B80'></tfoot><noframes id='602DB91B80'>
      • <optgroup id='602DB91B80'><strike id='602DB91B80'><sup id='602DB91B80'></sup></strike><code id='602DB91B80'></code></optgroup>
        5. <b id='602DB91B80'><label id='602DB91B80'><select id='602DB91B80'><dt id='602DB91B80'><span id='602DB91B80'></span></dt></select></label></b><u id='602DB91B80'></u>
          <i id='602DB91B80'><strike id='602DB91B80'><tt id='602DB91B80'><pre id='602DB91B80'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-27 16:51:46 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：knowledge   
                                        
                                      
                                      Page View：125
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          AltruBio raises $225 million to develop ulcerative colitis drug
                                
                            
          Next article：  
                                      
                                          After affirmative action ruling, medical educators look to 'holistic review'
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles